These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7588950)

  • 1. Keeping abreast of time.
    Ell PJ
    Eur J Nucl Med; 1995 Sep; 22(9):967-9. PubMed ID: 7588950
    [No Abstract]   [Full Text] [Related]  

  • 2. Nuclear medicine imaging of breast cancer.
    Van Eijck CH; Krenning EP; Kvols LK
    Nucl Med Commun; 1996 Nov; 17(11):925-7. PubMed ID: 8971862
    [No Abstract]   [Full Text] [Related]  

  • 3. Thallium-201 uptake in lung cancer.
    Chin BB; Zukerberg BW; Buchpiguel C; Alavi A
    J Nucl Med; 1995 Aug; 36(8):1514-9. PubMed ID: 7629600
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiopharmaceuticals for breast cancer imaging.
    Maffioli L; Seregni E; Chiti A; Molteni SN; Crippa F; Botti C; Bogni A; Agresti R; Bombardieri E
    Tumori; 1997; 83(2):512-4. PubMed ID: 9226006
    [No Abstract]   [Full Text] [Related]  

  • 5. Tissue characterization in nuclear oncology: its time has come.
    Lamki LM
    J Nucl Med; 1995 Feb; 36(2):207-10. PubMed ID: 7830115
    [No Abstract]   [Full Text] [Related]  

  • 6. Functional imaging using PET and SPECT in pediatric neurology.
    Messa C; Grana C; Lucignani G; Fazio F
    J Nucl Biol Med (1991); 1994 Mar; 38(1):85-8. PubMed ID: 8075181
    [No Abstract]   [Full Text] [Related]  

  • 7. Scintigraphic imaging of breast tumors.
    Maublant J
    Eur J Radiol; 1997 Jan; 24(1):2-10. PubMed ID: 9056144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highlights of the annual meeting of the European Association of Nuclear Medicine, Düsseldorf 1994.
    Knapp WH
    Eur J Nucl Med; 1995 Jan; 22(1):69-80. PubMed ID: 7698158
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
    Sandler MP; Videlefsky S; Delbeke D; Patton JA; Meyerowitz C; Martin WH; Ohana I
    J Am Coll Cardiol; 1995 Oct; 26(4):870-8. PubMed ID: 7560611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m sestamibi.
    Khalkhali I; Mena I; Diggles L
    Eur J Nucl Med; 1994 Apr; 21(4):357-62. PubMed ID: 8005161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Breast scintigraphy].
    Prats E; Razola P; García López F; Dolores Abós M; Banzo J
    Rev Esp Med Nucl; 2001 Feb; 20(1):47-70. PubMed ID: 11181333
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability.
    Berman DS; Kiat H; Van Train KF; Friedman J; Garcia EV; Maddahi J
    Am J Cardiol; 1990 Oct; 66(13):72E-79E. PubMed ID: 2145750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indium-111-Octreotide scintigraphy in differentiated thyroid carcinoma metastases that do not respond to treatment with high-dose I-131.
    Stokkel MP; Reigman HI; Verkooijen RB; Smit JW
    J Cancer Res Clin Oncol; 2003 May; 129(5):287-94. PubMed ID: 12750997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m-MIBI versus fluorine-18-FDG in diffuse multiple myeloma.
    el-Shirbiny AM; Yeung H; Imbriaco M; Michaeli J; Macapinlac H; Larson SM
    J Nucl Med; 1997 Aug; 38(8):1208-10. PubMed ID: 9255151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scintigraphic imaging of breast cancer: a review.
    Buscombe JR; Cwikla JB; Thakrar DS; Hilson AJ
    Nucl Med Commun; 1997 Aug; 18(8):698-709. PubMed ID: 9293500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m-sestamibi imaging in breast cancer: an alternative to thallium-201 imaging.
    Aktolun C
    J Nucl Med; 1994 Dec; 35(12):2055-6. PubMed ID: 7989994
    [No Abstract]   [Full Text] [Related]  

  • 17. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose.
    Dilsizian V; Arrighi JA; Diodati JG; Quyyumi AA; Alavi K; Bacharach SL; Marin-Neto JA; Katsiyiannis PT; Bonow RO
    Circulation; 1994 Feb; 89(2):578-87. PubMed ID: 8313546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer detection with sestamibi-Tc-99m and Tl-201 radionuclides in patients with non conclusive mammography.
    Alonso JC; Soriano A; Zarca MA; Guerra P; Alcazar R; Molino C
    Anticancer Res; 1997; 17(3B):1661-5. PubMed ID: 9179214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial viability estimated with 18F-FDG PET in patients with severe angina and 201Tl and 99mTc MIBI SPECT perfusion defects.
    Ahonen A; Voipio-Pulkki LM; Ruotsalainen U; Parviainen S; Ylinen SL; Haaparanta M; Korkeila P; Wegelius U
    Acta Radiol Suppl; 1991; 376():135-6. PubMed ID: 1666750
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer.
    Bassa P; Kim EE; Inoue T; Wong FC; Korkmaz M; Yang DJ; Wong WH; Hicks KW; Buzdar AU; Podoloff DA
    J Nucl Med; 1996 Jun; 37(6):931-8. PubMed ID: 8683314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.